KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biogen (BIIB) Revenue (2016 - 2025)

Historic Revenue for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $2.3 billion.

  • Biogen's Revenue fell 714.14% to $2.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $9.9 billion, marking a year-over-year increase of 221.89%. This contributed to the annual value of $9.9 billion for FY2025, which is 221.89% up from last year.
  • Latest data reveals that Biogen reported Revenue of $2.3 billion as of Q4 2025, which was down 714.14% from $2.5 billion recorded in Q3 2025.
  • Over the past 5 years, Biogen's Revenue peaked at $2.8 billion during Q3 2021, and registered a low of $2.3 billion during Q4 2025.
  • In the last 5 years, Biogen's Revenue had a median value of $2.5 billion in 2022 and averaged $2.5 billion.
  • Per our database at Business Quant, Biogen's Revenue crashed by 2462.52% in 2021 and then surged by 732.69% in 2025.
  • Quarter analysis of 5 years shows Biogen's Revenue stood at $2.7 billion in 2021, then decreased by 6.94% to $2.5 billion in 2022, then decreased by 6.2% to $2.4 billion in 2023, then rose by 2.87% to $2.5 billion in 2024, then decreased by 7.14% to $2.3 billion in 2025.
  • Its last three reported values are $2.3 billion in Q4 2025, $2.5 billion for Q3 2025, and $2.6 billion during Q2 2025.